Willem Karel Bleeker

Title: Willem Karel Bleeker: Innovator in Monovalent Antibodies

Introduction

Willem Karel Bleeker is a prominent inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of monovalent antibodies. With a total of 8 patents to his name, Bleeker's work has advanced the understanding and application of antibody technology.

Latest Patents

Among his latest patents, Bleeker has developed recombinant IgG4 monovalent antibodies. This invention relates to novel non-human transgenic animals that can produce monovalent antibodies upon antigenic stimulation. These animals are engineered with modified heavy chain transgenes, and the patent includes methods for producing these transgenic animals and immunizing them. Another significant patent is for recombinant monovalent antibodies and methods for their production. This invention provides monovalent antibodies with a long half-life when administered in vivo, along with methods for making such antibodies and pharmaceutical compositions that include them.

Career Highlights

Throughout his career, Bleeker has worked with notable organizations, including Genmab and the Ministry of Defence of the Netherlands. His work has been instrumental in advancing therapeutic applications of antibodies, making a lasting impact in the field of medicine.

Collaborations

Bleeker has collaborated with esteemed colleagues such as Paul Parren and Jan Van De Winkel. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Willem Karel Bleeker's contributions to the field of biotechnology, particularly in the area of monovalent antibodies, highlight his role as a leading inventor. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.